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High mobility group box 1 protein (HMGB1), a nuclear protein, is a critical cytokine that mediates the response to infection, in-
jury, and inﬂammation. The aim of our study was to elaborate a reliable in vitro model to investigate whether Mycobacterium bovis
BCG is able to induce HMGB1 secretion from the monocytic U-937 cells. Western blot technique was applied for the detection of
HMGB1 from supernatants of cells, following induction with Mycobacterium bovis BCG. Densitometric analysis revealed higher
concentrations of HMGB1 in cell supernatants stimulated with BCG than in the supernatants of the control, nonstimulated cells.
Further quantitation of the secreted HMGB1 was performed by ELISA. The BCG strain resulted in a higher amount of secreted
HMGB1 (450 ± 44ng/mL) than that of LPS (84 ± 12ng/mL) or Staphylococcus aureus (150 ± 14ng/mL). BCG and Phorbol −12-
myristate −13 acetate (PMA), added together, resulted in the highest HMGB1 secretion (645 ± 125ng/mL). The translocation of
the HMGB1 towards the cytoplasm following infection of cells with BCG was demonstrated by immunoﬂuorescence examina-
tions. Conclusion: Our pilot experiments draw attention to the HMGB1 inducing ability of Mycobacterium bovis. Assesment of the
pathophysiological role of this late cytokine in mycobacterial infections demands further in vitro and in vivo examinations.
Copyright © 2007 P´ eter Hofner et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
High mobility group box chromosomal protein 1 (HMGB1)
is an ubiquitous, extremely conserved (99% mammal iden-
tity) protein, to have DNA-binding properties; to partici-
pate in DNA transcription, replication, and repair; and also
to participate in neurite outgrowth and cell motility [1, 2].
Amphoterin is a 30-kD heparin-binding protein widely ex-
pressed in humans and other organisms, and it is abun-
dantly expressed in the developing brain as well as in vari-
ous immature and transformed cell lines. Unexpectedly, its
amino acid sequence turned out to be identical to HMGB1
[3]. In a new nomenclature of high-mobility group proteins,
amphoterin is called HMGB1 [4]. Further investigations re-
vealed that this has properties similar to those of proinﬂam-
matory cytokines [5–8]. HMGB1 has been demonstrated to
have the capacity to induce cytokines and to activate inﬂam-
matory cells when it is released extracellularly [8–10]. Ex-
tracellular HMGB1 functions as a proinﬂammatory late cy-
tokine, and activates monocytes and endothelial cells, lead-
ing to release of further cytokines [11, 12]. To act as a danger
signal and inﬂammatory mediator, HMGB1 must be trans-
ported extracellularly [13]. Moreover, HMGB1 can also be
actively secreted by stimulated macrophages or monocytes
in a process requiring acetylation of the molecule, which
enables translocation from the nucleus to secretory lyso-
somes [14]. In response to proinﬂammatory stimuli, that
is, proinﬂammatory cytokines such as TNF-α and IL-1, or
even. lipopolysacharide (LPS), HMGB1 may be actively se-
creted from monocyres and macrophages via the nonclas-
sical, vesicle-mediated pathway [15–17]. At the same time,
HMGB1 is a nuclear danger signal passively released by
necrotic cells that will induce inﬂammation [18], but not
from cells undergoing apoptosis.
In the classical experiment of Wang et al. [19] when
LPS was administered to mice to generate endotoxaemia, the
serumHMGB1levelsbegantoincrease12–18 hoursafterthe
peak levels of TNF, and IL-1. Administration of HMGB1 to2 Mediators of Inﬂammation
mice causes sepsis-like symptoms and death. HMGB1 has
been found as a downstream and late mediator in human
sepsisl too [20, 21]. During infections, microbial compo-
nents can be the activators of danger signals. So in infec-
tiousdiseases,HMGB1mayfunctionasasecretedorreleased
molecule to alert the host that the pathogen has invaded.
Gram-negative and Gram-positive bacteria are able to cause
sepsis, but little is known about the HMGB1 inducing abil-
ity of mycobacteria. We therefore set out to elaborate an in
vitro model, with which the HMGB1 inducing capacities of
diﬀerent bacteria or bacterial components could be investi-
gated. For this purpose, the monocytic cell line U-937 were
applied, and theextents of HMGB1secretion werecompared
following activation of these cells with E. coli LPS, Staphylo-
coccus aureus,a n dMycobacterium bovis BCG.
2. MATERIALS AND METHODS
2.1. Cellline
ThehumanmonocyticcellsU-937werepropagatedinRPMI
1640 medium supplemented with 100μg/mL ampicillin,
100μg/mL streptomycin, and 10% heat-inactivated fetal calf
serum (FCS, GIBCO) at 37◦C in a humidiﬁed CO2 incuba-
tor.
2.2. Cellstimulation
To analyze HMGB1 secretion from U-937 cells, culture me-
dia were replaced by OPTIMEM (GIBCO) medium, and the
cell number was adjusted to 106 cells/mL. The cells were
stimulated for 24 hours with: 5ng/mL Phorbol −12-myri-
state −13acetate(PMA,SIGMA),10μg/mLLPSE.coliO111:
B4 (SIGMA), heat-killed Staphylococcus aureus (SA) 108/mL,
or with Mycobacterium bovis BCG (107/mL).
2.3. Mycobacterialstrainandgrowthconditions
The Pasteur strain of M. bovis BCG (bacille Calmette-
Gu` erin) was kindly provided by David G. Russel (Depart-
ment of Microbiology and Immunology, Cormell University,
Ithaca, NY, USA). Bacteria were grown at 37◦C in Middle-
brook broth (Difco Laboratories, Detroit, Mich, USA) with
OADC supplement (oleic acid, albumin fraction V. dextrose
and catalase) containing 0.05% Tween-80. The chemicals
used to prepare the OADC supplement were purchased from
Sigma (DC, USA). Heat-killed bacteria were treated at 85◦C
for 30 minutes.
2.4. HMGB1westernblotanalysis
Supernatants of activated U-937 cells were ﬁrst concentrated
on a Centricon 10, with subsequent processing in Laemmli
buﬀer [22]. The 10-fold concentrated supernatants and
HMGB1 standards (human recombinant HMGB1; SIGMA;
and recombinant rat amphoterin-recAtn [23, 24]) were re-
solved in 12.5% SDS-PAGE under reducing conditions. Af-
ter electrophoresis, proteins were transferred to nitrocellu-
lose blotting membrane (Trans Blot BioRad) using a semi-
dry HOEFER transfer system. Membranes were blocked
overnight with 5% nonfat dry milk in PBS containing 0.05%
Tween. Filters were stained with aﬃnity-puriﬁed polyclonal
chicken antihuman HMGB1 antibody [3, 23], followed by
a horseradish peroxidase-conjugated goat antichicken anti-
body (ZYMED Laboratories, San Francisco, Calif, USA) and
developed with ECL-Plus (Amersham Pharmacia), and then
followed by exposure to X-ray ﬁlm (KODAK BIOMAX).
Densitometric analysis of the blots was performed by Image
Quant software (Amersham Bioscience , Buckinghamshire,
UK).
2.5. Massspectrometry
In-gel digestion: 1D SDS-PAGE separated, silver- or Coo-
massie Brilliant Blue-stained protein bands were cut, diced,
a n dw a s h e dw i t h2 5 m MN H 4HCO3 in 50% (v/v) ace-
tonitrile/water. After reduction with dithiothreitol (Sigma,
30min, 56◦C) and alkylation with iodoacetamide (30min,
room temperature, in the dark) the proteins were digested in
the gel with side-chain-protected, porcine trypsin (Promega,
Madison,Wis,USA.)in25mMNH4HCO3 buﬀer(pH ∼7.8)
for 4 hours at 37◦C. Tryptic digests were extracted and de-
salted on C18 ZipTip (Millipore, Bedford, Mass, USA.).
MS analysis of the unfractionated tryptic digests was
performed in positive-ion, reﬂectron mode, on a Reﬂex
IIIMALDI-TOF(matrix-assistedlaser-desorptionionization
time-of-ﬂight) mass spectrometer (Bruker, Karlsruhe, Ger-
many), using 2.5-dihydroxybenzoic acid as the matrix. Two-
point external calibration was applied, which guarantees a
mass accuracy within 200ppm.
The peak lists were generated with X-Tof (version 5.1.5)
software. Masses detected were submitted to a database
search on the NCBInr database (NCBInr 2005.10.29. 297-
2605 sequences; 1023918613 residues). The protein identi-
ﬁcation was conﬁrmed by sequence information obtained
from MS/MS (postsource decay) spectra, collected in 10–12
steps, lowering the reﬂector voltage by 25% in each step, and
then stitching the data together.
Low-energy CID experiments were performed on an Ag-
ilent Technologies XCT Plus (Agilent Technologies, Santa
Clara, Calif, USA) equipped with an AP MALDI source.
For these experiments 4-hydroxy-α cyano-cinnamic acid was
used as the matrix.
HMGB1ELISA
TheHMGB1concentrationsweredeterminedwitharecently
established available ELISA kit (Shino-Test Corp, Shagami-
hara, Japan) [24]. Brieﬂy, in the wells coated with anticalf
HMGB1 monoclonal antibody, samples to be measured and
standards—E. coli-derived HMGB1 (SIGMA)—were incu-
bated for 24 hours at 37◦C. After washing the wells for
5 times, a peroxidase-conjugated anti-HMGB1 monoclonal
antibody was added into the microwells and incubated for
120 minutes at room temperature. After washing the wells
for 5 times, 100uL of substrate solution was added and in-
cubated for 30 minutes at roome temperature. A stop solu-
tion was added, and the absorbance was measured at 450nm
(650nm reference) using microplate reader (Anthos LabtechP´ eter Hofner et al. 3
Instruments Eugendorf, Austria). The concentrations of the
samples were then calculated from the standard curve.
TNFELISA
The TNF-α concentrations in the supernatants of the con-
trol and stimulated cells were quantiﬁed by using TNF-α
ELISA kits (BIOSOURCE), according to the instructions of
the manufacturer.
2.6. Immunoﬂuorescence
Nonstimulated (control) or activated U-937 cells, cultured
on glass coverslips, were ﬁxed in 4% paraformaldehyde for
15 minutes at room temperature. Thereafter the cells were
washed 3 times with PBS and permeabilized with 0.3% Tri-
ton X-100 in PBS for 10 minutes at room temperature. Af-
ter 3 washing with PBS, the coverslips were saturated with
10% BSA in PBS for 1 hour. Cells were stained with chicken
anti-rec Atn antibody [3, 23] for 1 hour. Bound antibody
was detected with FITC-conjugated donkey antichicken IgY
(Jackson Immunoresearch Laboratories, Baltimore, Pike, Pa,
USA) for 45 minutes. Between all incubation step, the cells
were washed three times with PBS containing 0.2% BSA.
Coverslips were mounted on slides using Moviol (SIGMA).
Fluorescence signals were analyzed by confocal microscopy.
2.7. Confocalmicroscopyandsemiquantitative
assessmentofﬂuorescenceintensities
Serial images of the immunostained samples were captured
by Olympus FV1000 confocal laser scanning microscope
with standard parameter settings.
The immunoﬂuorescence of control, BCG and PMA
treatedcellswasquantitativelyanalyzedbyImageQuantsoft-
ware (Molecular Dynamics) as follows: 30 equal circular ar-
e a sc o v e r i n gt h ec e l l sw e r er a n d o m l ys e l e c t e do ne a c hi m a g e ;
the backgrounds of the selected areas were eliminated by
threshold set up; and the ﬂuorescence intensities/pixel values
of the randomly selected cells were quantiﬁed.
The mean and the standard deviation of the data gained
from serial circular areas were calculated by the Microsoft
Excel. The level of statistical signiﬁcance was determined by
two-tailed t-probe.
2.8. Statisticalanalysis
A l lv a l u e sa r ee x p r e s s e da sm e a n s± standard deviation (SD).
Sudent’spairedt-testwasusedforcomparisons,andP values
of less than .05 were considered statistically signiﬁcant.
3. RESULTS
3.1. IdentiﬁcationofHMGB1bywesternblotting
Western blotting of concentrated supernatants with aﬃnity
puriﬁed antirec Atn antibodies revealed a 25kD band which
comigrated with recAtn. E. coli derived recombinant human
HMGB1 gave also a considerable signal with this antibody,
but the two proteins featured diﬀerent molecular weights;
rec Atn was detected at 25kD, similarly to the samples from
U-937 cell supernatants. (Figure 1), and E. coli derived re-
combinant human HMGB1 at 30kD. In these experiments
aﬃnity-puriﬁed chicken IgY antibody against recombinant
rat Amphoterin (recAtn) was used [3], because the secreted
form of HMGB1 from cell supernatants was recognized by
this antibody satisfactory. Commercial monoclonal antibod-
ies failed to form considerable bands in Western blot exper-
iments (personal observations). The chicken antibody was
raised against recombinant rat Amphoterin (rec Atn), but
the rat amphoterin/HMGB1 diﬀers only with respect to two
amino acids from the human protein (Asp189 Glu and Glu
201 Ap) [3].
The level of HMGB1 was assessed by Western blotting
and by measuring the intensities of the immunoreactive
bands at 25kD. Densitometric analysis revealed higher con-
centrations of HMGB1 in cell supernatants stimulated either
with phorbol esther, or BCG (Figure 1) than in the super-
natants of the control, nonstimulated cells.
3.2. IdentiﬁcationofHMGB1bymassspectometry
As in Western blot experiments, two diﬀerent positive con-
trols (i.e., E. coli derived human recombinant HMGB1 and
rec Atn) were used, and the two proteins featured diﬀerent
molecular weights (30kD and 25kD, resp.), a mass spectom-
etry analysis was performed for the identiﬁcation of protein.
The identity of both proteins was conﬁrmed unambigu-
ously.In-geltryptic digestionandpeptide extractionwasfol-
lowed by mass spectrometry. MALDI-TOF analysis of the
unfractionated tryptic digest of the appropriate gel band
identiﬁed 79% of the masses detected as predicted tryp-
tic cleavage products of human HMGB1 (Figure 2). These
peptides represented approximately 56% of the protein se-
quence (see bold letters). The identity of 4 peptides: Lys30-
Lys43,H i s 31-Lys43,I l e 113-Lys127,a n dT y r 155-Arg163 was fur-
ther conﬁrmed by CID analyses. Masses, corresponding to
predicted His-tag tryptic peptides, were also detected, their
identity was conﬁrmed by PSD analysis. Similarly, 82% of
the masses detected in the second positive standard sample
(i.e., recAtn) matched predicted tryptic peptides of the rat
HMGB1. The identity of m/z 1520.76 as the predicted Ile113-
Lys127 peptide was further conﬁrmed by PSD analysis. These
peptides represented approximately 47.6% of the protein se-
quence (Figure 3, see bold letters).
HMGB1ELISA
ForamoresensitiveestimationoftheHMGB1inducingabil-
ity of M. bovis BCG and its comparison with other induc-
ers, the HMGB1 concentrations were determined with a re-
cently established [24] available ELISA kit (Shino-Test Corp,
Shagamihara, Japan). At the same time, we wished to check
whether the HMGB1 induction proceeded in parallel with
the TNF-α induction (Table 1). LPS resulted in a moder-
ate TNF-α production in U-937 cells (55 ± 6pg/mL),anda
weakHMGB1secretion(84 ±12ng/mL).Therewasahigher
concentration of TNF-α in the supernatant of U-937 cells4 Mediators of Inﬂammation
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Figure 1: Western blot analysis of U-937 supernatants for HMGB1. Supernatants 10-fold concentrated by Centricon 10, and HMGB1
standards (100ng) were run under reducing conditions on the gel (12.5% SDS-PAGE), transferred to nitrocellulose. Filters were stained
withaﬃnity-puriﬁedpolyclonalchickenanti-HMGB1antibody,followedbyahorseradishperoxidase-conjugatedgoatantichickenantibody
(ZYMED), developed with with ECL-Plus (Amersham, Pharmacia) followed by exposure to X-ray ﬁlm (KODAK BIOMAX). Densitometric
analysis of the blots were performed by Image Quant software (Amersham Bioscience).
Table 1: HMGB1 and TNF-α production of U-937 cells.
HMGB1ng/mL TNF-αpg/mL
Control 28 ± 51 5 ± 10
LPS 100ng/mL 84 ± 12∗ 55 ± 6∗
SA 150 ± 14∗ 650 ± 40∗
BCG 450 ± 44∗ 120 ± 11∗
PMA 5ng/mL 365 ± 49∗ 350 ± 50∗
PMA + SA 580 ± 15∗ 850 ± 120∗
PMA + BCG 645 ± 125∗ 900 ± 150∗
U-937 cells were induced for 24h with LPS, heat-killed Staphylococcus au-
reus ( S A ) ,5n g / m LP M A ,a n dMycobacterium bovis BCG. Supernatants were
processed for ELISA determination as it was described in Section 2.D a t aa r e
means ± SD of the results of 5 experiments.
∗ P < .001 versus Control.
incubated with heat-killed S. aureus (650 ± 40pg/mL), with
a considerable amount of HMGB1 in the supernatant of the
same cultures (150 ± 14ng/mL). Much greater amounts of
TNF-α and HMGB1 were measured in the PMA-treated cell
supernatants (350 ± 50pg/mL and 365 ± 49ng/mL, resp.).
The BCG strain resulted in a more pronounced HMGB1 se-
cretion than S. aureus did (450 ± 44ng/mL), though the
TNF-α inducing capacity was lower than that of S.aureus
(120 ± 11pg/mL). So mycobacteria induced almost the same
magnitude of HMGB1 as that induced by PMA. PMA and
BCG added at the same time resulted in the highest HMGB1
secretion (645 ± 125ng/mL; Table 1).
3.3. HMGB1relocalizesfromnucleusto
cytoplasmincellsactivatedwithBCG
The intracellular localization of HMGB1 in U-937 cells in-
cubated with BCG was investigated by immunoﬂuorescence
and analyzed by confocal microscopy. Nonstimulated cells
displayed strong staining for HMGB1 mostly restricted to
the nucleus. Eighteen hours after stimulation with BCG,
HMGB1 appeared to move from the nucleus, which is still
partlypositivetotheperipheryofthecells,whereitdisplayed
a punctuate staining in the cytoplasm. The ﬂuorescence in-
tensity therefore was signiﬁcantly lower in BCG stimulated
cells, because of the dispersity of the ﬂuorescence (Figure 4).
4. DISCUSSION
The present study demonstrates that U-937 cell model is re-
liable and highly reproducible for determination of HMGB1
secretion and TNF-α production after infection with M. bo-
vis BCG strain.
Although TNF itself can induce HMGB1 release, it con-
tributed only partly in HMGB1 release in our experiments.
The secretion of TNF-α from the U-937 cells was relatively
high following incubation of the cells wih heat-killed Staphy-
lococcus aureus, and there was considerable HMGB1 secre-
tion. In our experiments E. coli LPS induction resulted in a
lower TNF production and a weak HMGB1 secretion from
the monocytic cells (Table 1). Mycobacterium bovis BCG re-
sulted in a much lower TNF-α production, but it induced a
considerable amount of HMGB1. We speculate that the re-
ceptors (i.e., Toll-like receptors) recognizing cell wall com-
ponents of Gram-positive and Gram-negative bacteria may
not be equally involved in HMGB1 secretion, which serve
as HMGB1 receptors too [25]. Moreover, the intracellu-
lar mycobacteria may activate diﬀerent signals which lead
to HMGB1 secretion. TNF plays a critical role in host de-
fense against Mycobacterium tuberculosis [26]. Mycobacteria
are able to induce TNF production by diﬀerent pathways
[27]. However, it is very likely that this is not the only way
to induce HMGB1 release. Further studies are necessary to
elucidate the exact mechanism, that is, which signalization is
initiated by Mycobacterium bovis resulting in HMGB1 secre-
tion.P´ eter Hofner et al. 5
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Sequence coverage: 56%
1 MGKGDPKKPR GKMSSYAFFV QTCREEHKKK HPDASVNFSE FSKKCSERWK
51 TKSAKEKGKF EDMAKADKAR YEREMKTYIP PKGETKKKFK DPNAPKRPPS
101 AFFLFCSEYR PKIKGEHPGL SIGDVAKKLG EMWNNTAADD KQPYEKKAAK
151 LKEKYEKDIA AYRAKGKPDA AKKGVVKAEK SKKKKEEEED EEDEEEEEEE
201 EDEEDEDEEE DDDDE
916.59 [89–96] : identiﬁed m/z value as a HMGB-1
1946 : unidentiﬁed m/z value
1768.76 : identiﬁed m/z value as a His-tag
Figure 2: Mass spectral identiﬁcation of recombinant human HMGB-1 from E. coli. Database search with MS data identiﬁed the 30kDa
band as HMGB-1 protein, which was conﬁrmed by MS/MS spectra of m/z 1128.56 matching the sequence YEKDIAAYR of HMGB-1 and
1768.76 matching the sequence GSSHHHHHHSSGLVPR of hexahistidine peptide (His-tag). 79% of the masses detected matched this pro-
tein. Sequence positions are in square brackets.
In our immunoﬂuorescence experiments, the translo-
cation of HMGB1 from the nucleus toward the cytoplasm
was observed following induction of cells with BCG, which
proves an active secretion process. The HMGB-1 protein can
get out of the cells by two mechanisms: it can be secreted
actively mostly by living inﬂammatory cells, or released pas-
sively by damaged or necrotic cells. HMGB-1 lacks a secre-
tory signal peptide (similarly to interleukin-1β (IL-1β)[ 28]),
soitcannotbesecretedviatheGolgi-endoplasmicreticulum
pathway. In resting monocytes, HMGB1 shuttles through the
nuclear membrane to the cytosol or into the nucleus. The
activation signal leads to the acetylation of lysine residues
within the two nuclear localisation signal (NLS) sites on the
HMGB-1 molecule, thereby neutralising their charge and
making them unable to function as NLS. This is thought to
inhibit the relocalisation of the protein into the nucleus, so
the hyperacetylated HMGB-1 accumulates in the cytosol and
will be packed into secretory lysosomes. Hence, we conclude
that the translocation of HMGB1 from the nucleus toward
the cytoplasm, which was observed in our immunoﬂuores-
cence experiment following the induction of the cells with
BCG, may lead to an active secretion process.
Though U-937 cells are able to release a low level of
HMGB1 spontaneously, it is noteworthy, that they secrete a
considerable amount of HMGB1 only following PMA acti-
vation (Figure 1 and Table 1).PMA is a potent activator of
monocytes, resulting in diﬀerentiation too. Thus, it is very
probable that activation, or (much more likely) diﬀerentia-
tion of monocytes is an important factor which may facil-
itate their HMGB1 secretion. Incubation of the cells with
BCG resulted in HMGB1 secretion even without a coincu-
bation with PMA. However, the cells treated with PMA and
BCGsimultaneouslysecretedthehighestamountofHMGB1
(Figure 1 and Table 1).
The results of the ELISA measurements correlated well
with those of the Western blot experiments, but the sensitiv-
ity was higher. No ultraﬁltration was needed before testing
of the cell supernatants, as it was necessary in Western blot
experiments.
In the Western blot experiments the chicken anti-
HMGB1antibodyrecognizedboththeE.coli-derivedrecom-
binant human HMGB1, and the recombinant rat HMGB1,
but the two proteins featured slightly diﬀerent molecular
weights by SDS-PAGE (30kD versus 25kD). In order to de-
termine the structural diﬀerences, both proteins were in-
gel digested with trypsin and the resulting peptide mix-
tures were subjected to MALDI-TOF mass and PSD anal-
ysis. These results conﬁrmed the identity of the proteins.
Our “natural” samples, from the cell supernatants gave pos-
itive bands with this antibody at the same molecular weight,
as that of rat HMGB1. The exact reason for this is not yet
known. It is very likely, that naturally secreted HMGB1 from6 Mediators of Inﬂammation
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1 MGKGDPKKPR GKMSSYAFFV QTCREEHKKK HPDASVNFSE FSKKCSERWK
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Figure 3: Mass spectral identiﬁcation of recombinant rat HMGB1. Database search of the PMF data identiﬁed the 25kDa band as HMGB-1
protein, which was conﬁrmed by a PSD spectrum of m/z 1520.78 matching the sequence IKGEHPGLSIGDVAK of HMGB-1. 82% of the
masses detected matched this protein. Sequence positions are in square brackets.
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Figure 4: Immunoﬂuorescence analysis of HMGB1 in U-937 cells. Cells were ﬁxed, permeabilized, and stained with anti-HMGB1 chicken
IgY, thereafter with secondary antibody (FITC-labeled anti chicken antibody), and analyzed with confocal microscopy.P´ eter Hofner et al. 7
biological sources is not identical to the E. coli-derived re-
combinant HMGB1, and they may be recognized diﬀerently
by diﬀerent antibodies. This might be the explanation that
why not all commercial monoclonal antibodies are equally
able to detect HMGB1 from biological samples in Western
blot experiments (personal observations). The chicken anti-
HMGB1 antibody was successfully applied also to detect hu-
man HMGB1 from sera of septic patients in the study of
Sund´ en-Cullber et al. [20].
HMGB1 can occupy a central role in mediating the local
and systemic responses to invasion by pathogens. Our pilot
experiments draw attention to the HMGB1—inducing abil-
ity of Mycobacterium bovis, demonstrated in both Western
blot and ELISA experiments. Assessment the pathophysio-
logical role of this late cytokine in mycobacterial infections
demands further in vitro and in vivo experiments.
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